Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study
収録刊行物
-
- The Lancet
-
The Lancet 399 (10333), 1383-1390, 2022-04
Elsevier BV